T. Rowe Price Investment Management, Inc. - 28 Feb 2026 SCHEDULE 13G Report for APOGEE THERAPEUTICS INC COMMON STOCK (APGE)
- Filing Manager
- T. Rowe Price Investment Management, Inc.
- Reporting Manager
- T. Rowe Price Investment Management, Inc.
- Security
- APOGEE THERAPEUTICS INC COMMON STOCK
- Symbol
- APGE
- Shares outstanding
- 54,989,619 shares
- Disclosed Ownership
- 6,213,827 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G
- Filing time
- 06 Mar 2026, 12:57:46 UTC
- Date of event
- 28 Feb 2026
- SEC
- View on sec.gov
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 11% | 6,213,827 | 5,879,389 | 0 | Ellen York | Vice President |